Introduction
Several vitamin deficiencies have been described in association with Crohn's disease, including the B complex, B12, D and K. Other deficiencies may include iron, folic acid, calcium, magnesium, sodium, potassium or zinc (Avery Jones, Gummer and Lennard-Jones, 1968; Donaldson, 1973; Bockus, 1976) . As recommended treatment may include low residue diets or parenteral nutrition, both of which have a low vitamin C content, and the disease itself often causes malabsorption, it seems possible that vitamin C deficiency may be relatively common in Crohn's disease. It has been shown by Gerson and Fabry (1974) that vitamin C (ascorbic acid) concentrations in patients with Crohn's disease are decreased compared to normal controls. They postulated that fistula formation could be due to local ascorbate deficiency. Hughes and Williams (1978) (Hughes and Williams, 1978) .
Oral vitamin C, 600 mg daily for one week rapidly led to resolution of the skin lesions and nonspecific complaints of malaise, joint ache and weakness. The treatment was continued at a lower dose of 100 mg/day. Subsequent dietary assessment showed a very low daily intake of ascorbic acid of less than 10 mg daily. This was due to a self-imposed low residue diet adopted by the patient because of occasional colicky abdominal pains.
In view of this experience, it was decided to examine the next 9 out-patients with proved Crohn's disease for evidence of scurvy. Assessment of the ascorbic acid status, dietary intake of vitamin C and the macroscopic extent of the disease was also done, in order to establish whether subclinical ascorbic acid deficiency was as common in this group of Crohn's cases as in other series.
Methods
Leucocyte ascorbic acid, which most reliably reflects the state of tissue saturation (Burns, 1975) , was measured by the method of Denson and Bowers (1961) . The normal range of this method measures the ascorbic acid content of the buffy coat, i.e. leucocytes and platelets and is referred to as the Scurvy in Chron's disease 
Results
The results are shown in (Van Itallie, 1977) . As the patient was edentulous it is not surprising that she had no oral lesions and none of the gum changes often seen in this condition. It has been said that the LAA level falls to zero just before scurvy develops (Herman, Stibel and Greene, 1976) and in this, the present patient was not typical although the level of 25 nmol/108 WBC was far below the 'safe' antiscorbutic level of 85 nmol/108 WBC (Hughes and Williams, 1978 (Schrimshaw, 1975) . Some of these features are seen in Crohn's disease and it is possible that deficiency of vitamin C may be a factor in their aetiology.
However, it should be noted that vitamin C deficiency is not specific to Crohn's disease and is well recognized in conditions which damage the body, such as burns, fractures or surgical operations. These lead to rapid disappearance of the reduced vitamin (Davidson et al., 1975) . Deficiency is also seen in a wide variety of chronic illnesses, especially sepsis, neoplastic disease, etc., and is thought to be due to increased utilization of the vitamin (Burns, 1975; Latner, 1975) .
Vitamin C is a simple sugar with a molecular weight of 176. It is water soluble and an acid. It has been thought to be absorbed throughout the small intestine by passive diffusion (Nicholson and Charnock, 1942) , but recent work by Stevenson (1974) and confirmed by Mellors, Nahrwold and Rose (1977) shows an active transport mechanism of absorption by the ileum. Even after major resections of the small intestine resulting in a state resembling starvation, absorption of vitamin C is still maintained and deficiency is not usually a problem (Stewart and Booth, 1964; Preston and Ascunction, 1968) . However, LAA levels have been found to be decreased in steatorrhoea and clinical evidence of vitamin C deficiency has been reported (Williamson, Goldberg and Moore, 1967) . The present patients had not had small bowel resections and radiology had not shown internal fistulae. There was nothing to suggest steatorrhoea clinically, although faecal fats were not measured. Gerson and Fabry (1974) It is possible that there is an increased demand for vitamin C in Crohn's disease rather than malabsorption. It may be possible to correlate activity or severity of the disease to vitamih C levels, but this will require more study. There is no evidence that codeine phosphate, sulphsalazine, disodium cromoglycate or steroids affect LAA levels. Large doses of vitamin C are said to have no deleterious side effects (Burns, 1970) .
In view of the findings of vitamin C deficiency in this and other studies, it is recommended that regular vitamin C supplements (50-100 mg daily) should be given to all patients with Crohn's disease to prevent overt or subclinical vitamin C deficiency and possibly improve their sense of well being. In proved deficiency a dose of 200-1000 mg daily initially should be satisfactory (Losowsky, Walker and Kelleher, 1974) .
